Oocyte Cryopreservation by Slow Freezing and Vitrification
Launched by REPRODUCTIVE MEDICINE ASSOCIATES OF NEW JERSEY · Oct 15, 2010
Trial Information
Current as of June 25, 2025
Terminated
Keywords
ClinConnect Summary
Cryopreservation (freezing) of human gametes (unfertilized egg) provides a great potential to preserve or extend fertility in the face of disease and social circumstances (cancer diagnosis, delaying childbirth, single women, etc.). There are two methods for storage of oocytes (unfertilized eggs): slow freezing or vitrification (uses higher concentrations of cryoprotectant and faster cooling rates). Slow freezing is the standard method and has been successful for embryos since 1983 and more recently for oocytes. Recent reports indicate that vitrification may be more successful than slow free...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Age between 21 and 50 years, at the time of informed consent.
- • Subjects must agree to undergo intracytoplasmic sperm injection (ICSI)
- Exclusion Criteria:
- • Presence of any medical condition that contraindicates ovarian stimulation, in vitro fertilization or pregnancy.
About Reproductive Medicine Associates Of New Jersey
Reproductive Medicine Associates of New Jersey (RMANJ) is a leading fertility clinic dedicated to advancing reproductive health through innovative clinical practices and cutting-edge research. With a team of highly skilled specialists, RMANJ offers comprehensive services in assisted reproductive technology, including in vitro fertilization (IVF), egg freezing, and fertility preservation. The organization is committed to providing personalized care and leveraging the latest scientific advancements to optimize patient outcomes. Through its robust clinical trial initiatives, RMANJ aims to contribute to the ongoing evolution of reproductive medicine, fostering new therapies and improving access to effective fertility treatments for individuals and couples facing reproductive challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Richard T Scott, MD, HCLD
Study Director
RMA of NJ
Kathleen Ferry, BS
Study Chair
RMA of NJ
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials